1 宁章勇,赵德明,杨建民,等.实时荧光定量PCR检测PrP基因表达标准品质粒和标准曲线的构建[J].中国兽医学报,2005a,25(6):611~613. 2 宁章勇,赵德明,杨建民,等.小脑颗粒神经元细胞模型材料制备[J].中国兽医学报,2005b,25(4):403~405. 3 宁章勇,赵德明,杨建民,等.多肽PrP106-126对培养神经细胞朊蛋白基因表达的影响[J].中国病毒学,2006,21(6):609~613. 4 李佩玲,王雪卿,王姣玲,等.抗细胞凋亡基因Bcl-2和Bax与卵巢肿瘤的关系[J].哈尔滨医科大学学报,2000,34(3):174~176. 5 武书庚,程宗佳. 海绵状脑病研究进展[J].中国畜牧杂志,2010,46(18):43~44. 6 赵霞,董小平,周伟,等.人PrP基因体外诱导细胞凋亡的初步研究[J].病毒学报,2000,3(16):207~211. 7 葛忠源.朊病毒的研究进展[J].中国牧业通讯,2009(2):10~12. 8 Bounhar Y, Zhang Y, Goodyer C G, et al. Prion protein protects human neurons against Bax mediated apoptosis[J]. J Biol Chem, 2001, 276(42): 39145~39149. 9 Chiesa R, Drisaldi B, Quaglio E, et al. Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation[J]. Proc Natl Acad Sci USA, 2000, 97(10): 5574~5579. 10 Corsaro A, Thellung S, Villa V, et al. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation[J]. Ann N Y Acad Sci, 2003, 1010: 610~622. 11 Dada M A, Chetty R, Biddolph S C, et al. The immunoexpression of bcl-2 and p53 in Kaposi’s sarcoma[J]. Histopathology, 1996, 29(2): 159~163. 12 Donne D G, Viles J H, Groth D, et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible[J]. Proc Natl Acad Sci USA, 1997, 94(25): 13452~13457. 13 Evan G I, Wyllie A H, Gilbert C S, et al. Induction of apoptosis in fibroblasts by c-myc protein[J]. Cell,1992, 69(1): 119~128. 14 Fioriti L, Quaglio E, Massignan T, et al. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species[J]. Mol Cell Neurosci, 2005, 28(1): 165~176. 15 Garcion E, Wallace B, Pelletier L, et al. RNA mutagenesis and sporadic prion diseases[J]. J Theor Biol, 2004, 230(2): 271~274. 16 Hockenbery D M, Zutter M, Hickey W, et al. Bcl-2 protein is topographically restricted in tissue characterized by apoptotic cell death[J]. Proc Natl Acad Sci, 1991, 88: 6961~6965. 17 Marshall K A, Daniel S E, Cairns N, et al. Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: Studies on Parkinson’s and incidental Lewy body disease[J]. Biochem Biophys Res Commun,1997, 240(1): 84~87. 18 Misao J, Hayakawa Y, Ohno M, et al. Expression of Bcl-2 protein, an inhibitor of apoptosis, and bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction[J]. Circulation, 1996, 94(7): 1506~1512. 19 Sejvar J J, Schonberger L B, Belay E D. Transmissible spongiform encephalopathies[J]. J Am Vet Med Assoc, 2008, 233(11): 17005~17012. 20 Sheau Y H, Rosanna J L, Milton F, et al. Targeted over expression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis and increased germ cell tumorigenesis[J]. Endocrinology, 1996, 137(11): 4837~4843. 21 Tamm I, Wang Y, Sausville E, et al. IAP family protein surviving inhibits caspase activity and apoptosis induced by fas (CD95), bax, caspase, and anticancer drugs[J]. Cancer Res, 1998, 58(23): 5315~5320. 22 Wyllie A H, Rose K A, Morris R G, et al. Rodent fibroblast tumours expressing human myc and ras genes: Growth, metastasis and endogenous oncogene expression[J]. Br J Cancer, 1987,56(3): 251~259. 23 Zou H, Li Y, Liu X, et al. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9[J]. J Biol Chem, 1999, 274(17): 11549~11556. |